Claims
- 1. Process for the production of an 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid-(C.sub.1 -C.sub.4)-alkyl ester of the formula: ##STR3## wherein R.sub.1 is a (C.sub.1 -C.sub.4)-alkyl and R.sub.2 is a (C.sub.1 -C.sub.4)-alkyl or benzyl, characterized in that in a first step, 4-halo aceto acetic acid-(C.sub.1 -C.sub.4)-alkyl ester is reacted with an orthoformic acid-(C.sub.1 -C.sub.4)-trialkyl ester in an acid medium, the acid medium being sulfuric acid, a sulfonic acid or an acid ion exchanger, and the 4-halo-3-(C.sub.1 -C.sub.2 -alkoxy-2-E-butenoic acid-(C.sub.1 -C.sub.4)-alkyl ester, then in a second step, is reacted directly with a glycine-(C.sub.1 -C.sub.4)-alkyl or benzyl ester in the presence of base to the end product, said base being a weak inorganic base or a trialkylamine, 1 to 4 mols of the glycine-(C.sub.1 -C.sub.4)-alkyl or benzyl ester being used per mol of the haloalkoxybutenoic acid ester, the first and second reaction steps being each conducted at a temperature sufficient for said respective reaction to occur.
- 2. Process according to claim 1 wherein an aprotic or protic solvent with high polarity is used as the solvent for the reaction with glycine ester.
- 3. Process according to claim 2 wherein the reaction with the glycine ester is conducted at a reaction temperature of 60.degree. to 120.degree. C.
- 4. Process according to claim 1 wherein the reaction with the glycine ester is conducted at reaction temperature of 60.degree. to 120.degree. C.
- 5. Process according to claim 1 wherein the orthoformic acid -(C.sub.1 -C.sub.2)-trialkyl ester is a orthoformic acid trimethyl ester.
- 6. Process according to claim 1 wherein, between the first step and second step, the resultant 4-halo-3-(C.sub.1 -C.sub.2)-alkoxy-2-E-butenoic acid-(C.sub.1 -C.sub.4)-alkyl ester is isolated.
- 7. Process according to claim 1 wherein the weak inorganic base is sodium acetate, potassium carbonate or potassium hydrogencarbonate.
- 8. Process according to claim 1 wherein the tertiary alkyl amine is triethylamine.
- 9. Process according to claim 1 wherein 1.25 to 2 mols of the glycine -(C.sub.1 -C.sub.4)-alkyl or benzyl ester is used per mol of the haloalkoxybutenoic acid ester.
Priority Claims (3)
Number |
Date |
Country |
Kind |
4119/85 |
Sep 1985 |
CHX |
|
1958/86 |
May 1986 |
CHX |
|
2486/86 |
Jun 1986 |
CHX |
|
Parent Case Info
This is a divisional of Application Ser. No. 907,012, filed on Sept. 15, 1986.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
2535010 |
Croxall et al. |
Dec 1950 |
|
4118396 |
Pifferi et al. |
Oct 1978 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
850007 |
Jul 1949 |
DEX |
57-183756 |
Nov 1982 |
JPX |
Non-Patent Literature Citations (3)
Entry |
Koehler, Dissertation Bayreuth, (1985). |
MacKenzie et al., J.O.C.S. 20, No. 12, (1955), pp. 1695 and 1696. |
G. Pifferi et al., II Farmaco, Ed. Sc., (1977), vol. 32, 602. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
907012 |
Sep 1986 |
|